Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

The β₁ₐ Subunit of the Skeletal DHPR Binds to Skeletal RyR1 and Activates the Channel via Its 35-Residue C-Terminal Tail

dc.contributor.authorRebbeck, Robyn T.
dc.contributor.authorKarunasekara, Yamuna
dc.contributor.authorGallant, Esther M.
dc.contributor.authorBoard, Philip G.
dc.contributor.authorBeard, Nicole A.
dc.contributor.authorCasarotto, Marco G.
dc.contributor.authorDulhunty, Angela F.
dc.date.accessioned2016-04-07T01:28:23Z
dc.date.available2016-04-07T01:28:23Z
dc.date.issued2011-02-16
dc.date.updated2016-06-14T08:34:55Z
dc.description.abstractAlthough it has been suggested that the C-terminal tail of the β₁ₐ subunit of the skeletal dihyropyridine receptor (DHPR) may contribute to voltage-activated Ca²⁺ release in skeletal muscle by interacting with the skeletal ryanodine receptor (RyR1), a direct functional interaction between the two proteins has not been demonstrated previously. Such an interaction is reported here. A peptide with the sequence of the C-terminal 35 residues of β₁ₐ bound to RyR1 in affinity chromatography. The full-length β₁ₐ subunit and the C-terminal peptide increased [³H]ryanodine binding and RyR1 channel activity with an AC₅₀ of 450-600 pM under optimal conditions. The effect of the peptide was dependent on cytoplasmic Ca²⁺, ATP, and Mg²⁺ concentrations. There was no effect of the peptide when channel activity was very low as a result of Mg²⁺ inhibition or addition of 100 nM Ca²⁺ (without ATP). Maximum increases were seen with 1-10 μM Ca²⁺, in the absence of Mg²⁺ inhibition. A control peptide with the C-terminal 35 residues in a scrambled sequence did not bind to RyR1 or alter [³H]ryanodine binding or channel activity. This high-affinity in vitro functional interaction between the C-terminal 35 residues of the DHPR β₁ₐ subunit and RyR1 may support an in vivo function of β₁ₐ during voltage-activated Ca²⁺ release.
dc.description.sponsorshipThis work was supported by the National Health and Medical Research Council (471462 to A.F.D., M.G.C., and P.G.B.)en_AU
dc.identifier.issn0006-3495en_AU
dc.identifier.urihttp://hdl.handle.net/1885/100974
dc.publisherBiophysical Society
dc.relationhttp://purl.org/au-research/grants/nhmrc/471462
dc.rights© 2011 by the Biophysical Society
dc.sourceBiophysical Journal
dc.subjectamino acid sequence
dc.subjectanimals
dc.subjectcalcium
dc.subjectcalcium channels, l-type
dc.subjectmolecular sequence data
dc.subjectmuscle, skeletal
dc.subjectprotein binding
dc.subjectprotein stability
dc.subjectprotein subunits
dc.subjectrabbits
dc.subjectryanodine
dc.subjectryanodine receptor calcium release channel
dc.subjectstructure-activity relationship
dc.subjection channel gating
dc.titleThe β₁ₐ Subunit of the Skeletal DHPR Binds to Skeletal RyR1 and Activates the Channel via Its 35-Residue C-Terminal Tail
dc.typeJournal article
local.bibliographicCitation.issue4en_AU
local.bibliographicCitation.lastpage930en_AU
local.bibliographicCitation.startpage922en_AU
local.contributor.affiliationRebbeck, Robyn, College of Medicine, Biology and Environment, CMBE John Curtin School of Medical Research, Translational Bioscience, The Australian National Universityen_AU
local.contributor.affiliationKarunasekara, Yamuna, College of Medicine, Biology and Environment, CMBE John Curtin School of Medical Research, Translational Bioscience, The Australian National Universityen_AU
local.contributor.affiliationGallant, Esther, College of Medicine, Biology and Environment, CMBE John Curtin School of Medical Research, Genome Sciences, The Australian National Universityen_AU
local.contributor.affiliationBoard, Philip, College of Medicine, Biology and Environment, CMBE John Curtin School of Medical Research, Translational Bioscience, The Australian National Universityen_AU
local.contributor.affiliationBeard, Nicole, College of Medicine, Biology and Environment, CMBE John Curtin School of Medical Research, Translational Bioscience, The Australian National Universityen_AU
local.contributor.affiliationCasarotto, Marco, College of Medicine, Biology and Environment, CMBE John Curtin School of Medical Research, Translational Bioscience, The Australian National Universityen_AU
local.contributor.affiliationDulhunty, Angela, College of Medicine, Biology and Environment, CMBE John Curtin School of Medical Research, Translational Bioscience, The Australian National Universityen_AU
local.contributor.authoruidu8404877en_AU
local.description.notesImported from ARIESen_AU
local.identifier.absfor060110en_AU
local.identifier.absseo970111en_AU
local.identifier.ariespublicationf2965xPUB1349en_AU
local.identifier.citationvolume100en_AU
local.identifier.doi10.1016/j.bpj.2011.01.022en_AU
local.identifier.essn1542-0086en_AU
local.identifier.scopusID2-s2.0-79951820580
local.identifier.thomsonID000287624000018
local.publisher.urlhttp://www.biophysics.org/en_AU
local.type.statusPublished Versionen_AU

Downloads

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
884 B
Format:
Item-specific license agreed upon to submission
Description:
abcd